Pharmacogenomics of Antihypertensive drugs: Rationale and Design of the Pharmacogenomic Evaluation of Antihypertensive Responses (PEAR) Study

BACKGROUND: Selection of antihypertensive therapy is often empiric and use of genetic information to guide drug therapy selection holds future promise. TRIAL DESIGN: The objective of this trial is to identify the genetic determinants of the antihypertensive and adverse metabolic responses to a thiaz...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Johnson, Julie A., Boerwinkle, Eric, Zineh, Issam, Chapman, Arlene B., Bailey, Kent, Cooper-DeHoff, Rhonda M., Gums, John, Curry, R. Whit, Gong, Yan, Beitelshees, Amber L., Schwartz, Gary, Turner, Stephen T.
Format: Artigo
Idioma:Inglês
Publicat: 2009
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC2671287/
https://ncbi.nlm.nih.gov/pubmed/19249413
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ahj.2008.11.018
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars